Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment
<p>Abstract</p> <p>Cancer research has devoted most of its energy over the past decades on unraveling the control mechanisms within tumor cells that govern its behavior. From this we know that the onset of cancer is the result of cumulative genetic mutations and epigenetic alterati...
Main Authors: | Heuvers Marlies E, Aerts Joachim G, Cornelissen Robin, Groen Harry, Hoogsteden Henk C, Hegmans Joost P |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-12-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2407/12/580 |
Similar Items
-
Improving lung cancer survival; time to move on
by: Heuvers Marlies E, et al.
Published: (2012-12-01) -
Tailoring therapies to counter the divergent immune landscapes of breast cancer
by: Sherif Attalla, et al.
Published: (2023-02-01) -
Oncolytic bacteria VNP20009 expressing IFNβ inhibits melanoma progression by remodeling the tumor microenvironment
by: Lina Liu, et al.
Published: (2024-04-01) -
TRAIL-dependent apoptosis of peritoneal mesothelial cells by NK cells promotes ovarian cancer invasion
by: Anna Mary Steitz, et al.
Published: (2023-12-01) -
Downregulation of IRF8 in alveolar macrophages by G-CSF promotes metastatic tumor progression
by: Stephanie L. Tzetzo, et al.
Published: (2024-03-01)